In Re: Fosamax Products Liability Litigation
Case Number:
1:06-md-01789
Court:
Nature of Suit:
365 Personal Inj. Prod. Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Andrus Boudreaux
- Ashcraft & Gerel
- Aylstock Witkin
- Bahe Cook
- Balkan & Patterson
- Beasley Allen
- Blank Rome
- Blizzard Greenberg
- Bond Schoeneck
- Bowman & Brooke
- Brandi Law Firm
- Brown & Crouppen
- Bryan Cave
- Burg Simpson
- Butler Snow LLP
- Carey Danis
- Cellino Law
- Clark Hill
- Coffey Burlington
- Covington & Burling
- Curtis Law Group
- Dughi Hewit
- Flaster Greenberg
- Fleming Nolen
- Goldenberg Heller
- Goldman Ismail
- Goodwin Procter
- Greenberg Traurig
- Henderson Franklin
- Heninger Garrison
- Hensley Legal Group
- Hill Ward Henderson
- Hissey Mulderig
- Holland & Knight
- Hughes Hubbard
- Johnson & Bell
- King & Spalding
- Kirkland & Ellis
- K&L Gates
- Krupnick Campbell
- Law Offices of Charles H. Johnson
- Law Offices of Pardy & Rodriguez
- Levin Papantonio
- Liskow & Lewis
- Lopez McHugh
- McAfee & Taft
- McCumber Daniels
- Miller Weisbrod
- Moore Hill & Westmoreland
- Moravcik Threadgill
- Morelli Law Firm
- Morris Duffy
- Murray Law Firm
- Neblett Beard
- Nilan Johnson
- Norton Rose
- Osborn Law PC
- Parks & Crump
- Peiffer Wolf
- Peterson & Associates PC
- Reich & Binstock
- Robins Kaplan
- Robinson Calcagnie
- Rushton Stakely
- Schneider Wallace
- Seeger Weiss
- Serpico Petrosino
- Sills Cummis
- Smolen Smolen
- Solberg Stewart
- Squire Patton
- Stinson LLP
- Stritmatter Kessler
- Terrell Hogan
- The Edward A. Williamson Law Firm
- The Florida Law Group
- Tucker Ellis
- Valad & Vecchione
- Venable LLP
- Wagstaff & Cartmell
Companies
- Aurobindo Pharma Ltd.
- Genentech Inc.
- McKesson Corp.
- Merck & Co. Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- The Procter & Gamble Co.
Sectors & Industries:
-
December 19, 2013
Generic Fosamax Users Must Give More Details In MDL
A New York federal judge on Wednesday ordered plaintiffs in multidistrict litigation against Teva Pharmaceuticals USA Inc. to divulge when they had taken a generic version of the bone drug Fosamax, in order to back the claim that Teva's failure to update the drug's labeling had led to their jaw injuries.
-
December 09, 2013
Merck Settles Fosamax Jaw-Injury Claims For $28M
Resolving long-running multidistrict litigation in New York, Merck & Co. Inc. agreed Monday to pay $27.7 million to settle hundreds of lawsuits claiming its bone drug Fosamax caused a condition known as osteonecrosis of the jaw.
-
October 02, 2013
Merck Opposes Delay In Wind-Down Of Fosamax MDL
In a turnaround Friday, Merck & Co. Inc. urged a New York federal judge to stick to the planned wind-down of multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax, after plaintiffs asked for a stay in the transfer of cases.
-
August 30, 2013
Fosamax MDL To Wind Down More Swiftly Than Merck Wanted
A New York federal judge decided Thursday to transfer cases out of the Fosamax jaw injury multidistrict litigation against Merck & Co. Inc. at an even faster pace than proposed by the plaintiffs, who have pushed strongly for a speedy transition.
-
August 22, 2013
Merck Can't Force Fosamax Plaintiffs To Verify Injuries
A New York federal judge on Thursday refused to force hundreds of alleged victims of Merck & Co.'s bone drug Fosamax to substantiate their injuries or else face dismissal from multidistrict litigation over the drug, saying the process would devolve into a fight on the merits of each case.
-
August 19, 2013
Merck, Plaintiffs Bicker Over Fosamax MDL Wind-Down Plans
Merck & Co. Inc. and the plaintiffs suing the company over jaw injuries allegedly caused by the bone drug Fosamax proposed competing plans for the wind-down of multidistrict litigation on Monday, with the drugmaker claiming its opponents seek to "dump" the cases across the country.
-
August 15, 2013
Labeling Update Claims Survive Dismissal In Fosamax MDL
A New York federal judge ruled Thursday that manufacturers of generic versions of the bone drug Fosamax can be held liable for failing to match their warning labels to the brand-name label, in multidistrict litigation over a jaw condition allegedly caused by the drug.
-
August 15, 2013
Merck, Plaintiffs Fail To Reach Deal In Fosamax Jaw MDL
Merck & Co. Inc. and a group of plaintiffs in multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax broke off settlement talks on Wednesday, a day after a judge peppered the drugmaker with questions about why it has not yet resolved the litigation.
-
August 12, 2013
Merck Wants Fosamax Plaintiffs To Cough Up Evidence
Merck & Co. on Monday asked the federal judge handling multidistrict litigation over the safety of its bone drug Fosamax to force some plaintiffs to substantiate their claims, a move that could see hundreds of cases cut from the MDL.
-
July 01, 2013
Merck Can't Duck Jury Award In Fosamax Bellwether Suit
A New York federal judge on Monday denied Merck & Co. Inc.'s attempt to wipe out a $285,000 plaintiff verdict in a bellwether trial in multidistrict litigation claiming the bone drug Fosamax causes jaw deterioration, rejecting its argument that its warning was adequate.